GSK India aims to double revenue to ₹8K cr by FY30: MD Bhushan Akshikar
· business-standard.com
GSK India aims to double revenue to ₹8,000 crore by FY30, with oncology and adult vaccines emerging as key growth drivers alongside its general-medicines portfolio
Oncology currently makes a negligible contribution to GSK India’s revenue. How materially can it contribute over the next five years?
More than a decade ago,...